Literature DB >> 25144631

Characterization of GAB1 expression over the menstrual cycle in women with and without polycystic ovarian syndrome provides a new insight into its pathophysiology.

K L Roemer1, S L Young, R F Savaris.   

Abstract

CONTEXT: In a previous microarray analysis, GRB2-associated binding protein 1 (GAB1), a docking protein closely related to the insulin receptor substrate, was down-regulated in endometrium of women with polycystic ovary syndrome (PCOS).
OBJECTIVE: The objective of the study was to characterize the cyclic expression of endometrial GAB1 in vivo in normal women and those with PCOS as well as investigate the possible mechanisms of endometrial regulation of GAB1 expression and action in vitro.
DESIGN: This was an experimental and case-control study.
SETTING: The study was conducted at a tertiary university hospital. PATIENTS: Normal proven fertile women (controls; n = 31) and women with PCOS (cases; n = 26) participated in the study.
INTERVENTIONS: INTERVENTIONS included timed endometrial biopsies at different phases of the menstrual cycle. Ishikawa cells were cultured with β-estradiol (E2), medroxyprogesterone acetate, and E2 + medroxyprogesterone acetate. Transfection of small interfering RNA for GAB1 in Ishikawa cells incubated with or without insulin. MAIN OUTCOME MEASURES: GAB1 mRNA expression in Ishikawa cells and in endometrium of cases and controls was measured. Protein expression of phosphorylated MAPK by Western blot was also measured. Immunohistochemical localization and expression of phosphorylated GAB1 in endometrium was also measured, using a digital histological score.
RESULTS: In endometrial tissue, GAB1 mRNA was reduced in the proliferative phase of PCOS women, compared with controls (P = .003; ANOVA). When all the phases of the menstrual cycle were grouped, GAB1 protein expression was reduced in endometrium of PCOS women (P < .0001; Student t test). E2 increases GAB1 mRNA expression in Ishikawa cells (P = .001; ANOVA). Phosphorylated MAPK is reduced in cells transfected with small interfering RNA for GAB1 (P = .008; ANOVA) and incubated with insulin.
CONCLUSIONS: GAB1 mRNA expression is positively modulated by E2. Endometrial GAB1 protein and mRNA expression are reduced in women with PCOS, suggesting that the endometrium of PCOS women have a defect in insulin signaling due to GAB1 down-regulation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25144631      PMCID: PMC4223437          DOI: 10.1210/jc.2014-2128

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  24 in total

1.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 2.  Endometrium in PCOS: Implantation and predisposition to endocrine CA.

Authors:  Linda C Giudice
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2006-06       Impact factor: 4.690

3.  Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action.

Authors:  Emilie A Bard-Chapeau; Andrea L Hevener; Shinong Long; Eric E Zhang; Jerrold M Olefsky; Gen-Sheng Feng
Journal:  Nat Med       Date:  2005-04-10       Impact factor: 53.440

4.  Epidermal growth factor signaling mediated by grb2 associated binder1 is required for the spatiotemporally regulated proliferation of olig2-expressing progenitors in the embryonic spinal cord.

Authors:  Yoshika Hayakawa-Yano; Keigo Nishida; Shinichi Fukami; Yukiko Gotoh; Toshio Hirano; Toshiyuki Nakagawa; Takuya Shimazaki; Hideyuki Okano
Journal:  Stem Cells       Date:  2007-03-01       Impact factor: 6.277

Review 5.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

6.  Function, regulation and pathological roles of the Gab/DOS docking proteins.

Authors:  Franziska U Wöhrle; Roger J Daly; Tilman Brummer
Journal:  Cell Commun Signal       Date:  2009-09-08       Impact factor: 5.712

7.  Identification of major ERK-related phosphorylation sites in Gab1.

Authors:  Stefan Lehr; Jorg Kotzka; Haluk Avci; Albert Sickmann; Helmut E Meyer; Armin Herkner; Dirk Muller-Wieland
Journal:  Biochemistry       Date:  2004-09-28       Impact factor: 3.162

8.  Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma.

Authors:  Ann Marie Egloff; Mary E Rothstein; Raja Seethala; Jill M Siegfried; Jennifer Rubin Grandis; Laura P Stabile
Journal:  Clin Cancer Res       Date:  2009-10-13       Impact factor: 12.531

9.  A Grb2-associated docking protein in EGF- and insulin-receptor signalling.

Authors:  M Holgado-Madruga; D R Emlet; D K Moscatello; A K Godwin; A J Wong
Journal:  Nature       Date:  1996-02-08       Impact factor: 49.962

10.  Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles.

Authors:  Ricardo F Savaris; Jeremy M Groll; Steven L Young; Franco J DeMayo; Jae-Wook Jeong; Amy E Hamilton; Linda C Giudice; Bruce A Lessey
Journal:  J Clin Endocrinol Metab       Date:  2011-03-16       Impact factor: 5.958

View more
  2 in total

1.  Endometrial BCL6 Overexpression in Eutopic Endometrium of Women With Endometriosis.

Authors:  Emily Evans-Hoeker; Bruce A Lessey; Jae Wook Jeong; Ricardo F Savaris; Wilder A Palomino; Lingwen Yuan; David P Schammel; Steven L Young
Journal:  Reprod Sci       Date:  2016-05-24       Impact factor: 3.060

2.  Small leucine-rich proteoglycans (SLRPs) in the endometrium of polycystic ovary syndrome women: a pilot study.

Authors:  Ricardo Santos Simões; José Maria Soares; Manuel J Simões; Helena B Nader; Maria Cândida P Baracat; Gustavo Arantes R Maciel; Paulo C Serafini; Ricardo Azziz; Edmund C Baracat
Journal:  J Ovarian Res       Date:  2017-08-08       Impact factor: 4.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.